← Back to Clinical Trials
Recruiting NCT07256275

NCT07256275 Peer Influences in Alcohol and Sexual Violence Among Marines Dyads

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07256275
Status Recruiting
Phase
Sponsor Georgia State University
Condition Peer Influence
Study Type OBSERVATIONAL
Enrollment 320 participants
Start Date 2026-03-18
Primary Completion 2030-07-01

Eligibility & Interventions

Sex Male only
Min Age 21 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 320 participants in total. It began in 2026-03-18 with a primary completion date of 2030-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this experimental study is to examine the complex and multifaceted influence of peers on alcohol-involved sexual violence perpetration (ASVP) in U.S. Marine Corps (USMC) men. The specific aims are: Aim 1: Use ecological momentary assessment (EMA) to examine event-level effects of one's own alcohol use, peer alcohol use, and injunctive norms on ASVP intentions among dyads of Marine men who drink together (n=160 dyads; 320 total participants). Aim 2: Examine the individual and peer effects on ASVP behavior in an experimental paradigm with a gender x confederate (potential victim) intoxication status design. In-the-moment dyad-peer verbalized encouragement for ASVP ("go cues") will be assessed by qualitatively coding verbalizations during the interaction. Aim 3: Examine modifiable risk factors on ASVP intentions in vivo (Aim 1; EMA) and ASVP behavior in vitro (Aim 2; experiment) settings. Participants will complete: 1) an individual orientation session with informed consent, baseline assessment, and EMA demo; 2) 14 days of EMA completed individually; and 3) a dyadic session to complete an experimental paradigm via videoconferencing. All study procedures will be completed in off-duty time as to not interfere with military duties.

Eligibility Criteria

Inclusion Criteria: * Men * Aged 21 or older * Currently serving in the United States Marine Corps (USMC) * Marine dyads must have engaged in heavy episodic drinking (≥5 drinks in less than two hours) together at least twice in the past month * Marine dyads must rate their peer at a minimum of "somewhat important" on the Important People Interview. Exclusion Criteria: * The only exclusion criteria is not meeting inclusion criteria.

Contact & Investigator

Central Contact

Amanda K Gilmore, PhD

✉ agilmore12@gsu.edu

📞 (404) 413-2000

Principal Investigator

Amanda K Gilmore, PhD

PRINCIPAL INVESTIGATOR

Georgia State University

Frequently Asked Questions

Who can join the NCT07256275 clinical trial?

This trial is open to male participants only, aged 21 Years or older, studying Peer Influence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07256275 currently recruiting?

Yes, NCT07256275 is actively recruiting participants. Contact the research team at agilmore12@gsu.edu for enrollment information.

Where is the NCT07256275 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT07256275 clinical trial?

NCT07256275 is sponsored by Georgia State University. The principal investigator is Amanda K Gilmore, PhD at Georgia State University. The trial plans to enroll 320 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology